Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
WuXi AppTec
Pharma
Legend Biotech, Taiho-Cullinan, WuXi AppTec—Fierce Pharma Asia
Legend Biotech posted its first profit. Taiho and Cullinan's EGFR drug scored a phase 3 win. WuXi AppTec won round 1 in its lawsuit against DOD.
Angus Liu
Aug 14, 2026 8:52am
WuXi AppTec wins temporary relief in DOD classification feud
Aug 11, 2026 11:33am
Astellas, Takeda, RA Capital—Fierce Pharma Asia
Jun 12, 2026 8:23am
WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
Jun 9, 2026 12:24pm
WuXi Bio's contracting business saw influx of US clients in '25
Mar 24, 2026 10:56am
Biosecure Act slips into key US defense bill
Dec 9, 2025 11:00am
